GlaxoSmithKline signed a $300 million research and development deal with mail gene profiling company 23andMe, gaining access to four million customers DNA information. Health and ancestry service ...
After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are ...